Visual hypersensitivity in patients treated with anti-calcitonin gene-related peptide (receptor) monoclonal antibodies.
Authors
de Vries Lentsch S, Perenboom MJL, Carpay JA, MaassenVanDenBrink A, Terwindt GM
Abstract
To evaluate the effect of treatment with anti-calcitonin gene-related peptide (CGRP; receptor) antibodies on visual hypersensitivity in patients with migraine.
